Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Dickmann
Stephan Becker

Showing results (261-270 of 299) with videos related to

Pageof 30
Sort By:
Antiviral Research|February 12, 2018
The molecular tweezer CLR01 inhibits Ebola and Zika virus infectionAnnika E Röcker, Janis A Müller, Erik Dietzel, et al.
The Lancet. Infectious Diseases|August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialAngela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
Plos One|November 21, 2017
Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumoniaKristina Dietert, Birgitt Gutbier, Sandra M Wienhold, et al.
Ebiomedicine|April 25, 2017
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV ImmunizationChristine Dahlke, Rahel Kasonta, Sebastian Lunemann, et al.
The Journal of Allergy and Clinical Immunology|August 17, 2018
Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinovirusesDaniel P Potaczek, Sebastian D Unger, Nan Zhang, et al.
Journal of Virology|September 11, 2015
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine PlatformAnna H Malczyk, Alexandra Kupke, Steffen Prüfer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa FeverVanessa N Raabe, Gerrit Kann, Bruce S Ribner, et al.
The Lancet. Infectious Diseases|April 24, 2020
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trialTill Koch, Christine Dahlke, Anahita Fathi, et al.
Viruses|August 28, 2021
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 InfectionSandro Halwe, Alexandra Kupke, Kanika Vanshylla, et al.
Vaccine|June 6, 2020
Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in GuineaYap Boum, Aitana Juan-Giner, Matt Hitchings, et al.
Pageof 30

Showing results (261-270 of 299) with videos related to

Sort By:
Pageof 30
Antiviral Research|February 12, 2018
The molecular tweezer CLR01 inhibits Ebola and Zika virus infectionAnnika E Röcker, Janis A Müller, Erik Dietzel, et al.
The Lancet. Infectious Diseases|August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialAngela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
Plos One|November 21, 2017
Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumoniaKristina Dietert, Birgitt Gutbier, Sandra M Wienhold, et al.
Ebiomedicine|April 25, 2017
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV ImmunizationChristine Dahlke, Rahel Kasonta, Sebastian Lunemann, et al.
The Journal of Allergy and Clinical Immunology|August 17, 2018
Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinovirusesDaniel P Potaczek, Sebastian D Unger, Nan Zhang, et al.
Journal of Virology|September 11, 2015
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine PlatformAnna H Malczyk, Alexandra Kupke, Steffen Prüfer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa FeverVanessa N Raabe, Gerrit Kann, Bruce S Ribner, et al.
The Lancet. Infectious Diseases|April 24, 2020
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trialTill Koch, Christine Dahlke, Anahita Fathi, et al.
Viruses|August 28, 2021
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 InfectionSandro Halwe, Alexandra Kupke, Kanika Vanshylla, et al.
Vaccine|June 6, 2020
Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in GuineaYap Boum, Aitana Juan-Giner, Matt Hitchings, et al.
Pageof 30